Abstract:Biotransformation of bavachinin (1) was investigated using three fungal cell cultures of Aspergillus flavus ATCC 30899, Cunninghamella elegans CICC 40250 and Penicillium raistrickii ATCC 10490, respectively. Two major converted products were identified by LC/MS, H-1 NMR and C-13 NMR and X-ray diffraction. Two biocatalyst systems, A. flavus ATCC 30899 and C. elegans CICC 40250 cell cultures, showed a great capacity of hydroxylation and two hydroxyl groups were attached at C-2 '' and C-3 '' positions in the side chain of the bavachinin A-ring, resulting in the formation of the same compound with a name, (S)-64(R)-2,3-dihydroxy-3-methylbuty1)-2-(4-hydroxypheny1)-7-methoxychromen-4-one (2). On the other hand, P. raistricicii ATCC 10490 cell cultures possessed the ability to reduction at C-4 of the substrate C-ring, resulting in the production of (2S,4R)-2-(4-hydroxyphenyI)-7-methoxy-6-(3-methylbut-2-en-1-yl)chromen-4-ol (3). Furthermore, the in vitro anti-tumor activities of the above compounds were evaluated by MIT assay. Compared with the substrate (1), product 3 possessed stronger inhibition activity on the human breast cancer cell line (MCF-7) and slightly lower inhibition activities against Hep G2, HeLa, Hep-2 and A549 cells lines; while the hydroxyl product 2 possessed much lower inhibition activity on tumor cells lines, which might be related to the insertion of two hydroxyl groups. Compounds 2 and 3 were considered to be novel. It was also the first time to biotransform bavachinin (1) by these three fungi, which suggested the potential role of microbial enzymes to synthesize novel compounds from plant secondary metabolites.(C) 2013, The Society for Biotechnology, Japan. All rights Reserved.

Specific 12Β-Hydroxylation of Cinobufagin by Filamentous Fungi

Microbial hydroxylation of cinobufagin by Mucor spinosus.

Substrate specificity for the 12beta-hydroxylation of bufadienolides by Alternaria alternata.

Microbial transformation of cinobufagin by Syncephalastrum racemosum.

Biotransformation of Cinobufagin by Cell Suspension Cultures of Catharanthus Roseus and Platycodon Grandiflorum

Microbial Hydroxylation of Bufalin by Cunninghamella Blakesleana and Mucor Spinosus.

Glucosylation of Cinobufagin by Cultured Suspension Cells of Catharanthus Roseus

Cytotoxic Biotransformed Products from Cinobufagin by Mucor Spinosus and Aspergillus Niger

Biotransformation of arenobufagin and cinobufotalin by Alternaria alternata

Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani

A New Bufadienolide Obtained from the Biotransformation of Cinobufagin Byalternaria Alternata

Selective dehydrogenation of resibufogenin and cinobufagin at 3-OH by Pseudomonas aeruginosa

Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships.

Identification of cinobufagin metabolites in the bile of rats.

Microbial transformation of three bufadienolides by Penicillium aurantigriseum and its application for metabolite identification in rat

Microbial Transformation of Bufotalin by Alternaria Alternata As 3.4578

Studies on the metabolism of cinobufagin and cinobufotalin by human intestinal bacteria

Biotransformation of Bavachinin by Three Fungal Cell Cultures

Gastrodin Production from p -2-Hydroxybenzyl Alcohol Through Biotransformation by Cultured Cells of Aspergillus foetidus and Penicillium cyclopium

New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

Concise Synthesis of Bufadienolide Cinobufagin via Late-Stage Sin-glet Oxygen Oxidation/Rearrangement Approach